kentucky semaglutide law office glp-1 gastric intestinal obstruction gastrointestinal attorney stomach paralysis in kentucky glp-1 stomach kentucky semaglutide digestive blockage law – semaglutide gastroparesis law office in

Branded medications go through rigorous FDA review, offer consistent dosing, and come with established safety data from large clinical trials

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program provided the primary evidence base, showing continued efficacy without significant safety concerns emerging over extended use

Patients were deemed eligible for participation if they were at least 18 years of age, diagnosed with type 2 diabetes and insufficient glycemic control, measured by HbA1c levels, as well as treatment with diet and exercise or a stable dose of metformin

Research Articles on Semaglutide